pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Jakafi · news · pharmadog
← back to Jakafi
News mentioning Jakafi
11
stories
Sep 1, 26
Mid-cap biotechs join Trump’s latest round of drug pricing deals
biopharma dive
Sep 1, 26
9 midsize drugmakers climb aboard Trump’s MFN train
biospace
Aug 31, 26
FDA OKs Takeda, Protagonist drug for rare blood cancer
biopharma dive
Jul 29, 26
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
Jul 28, 26
Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options
fiercebiotech
Jun 15, 26
Lilly scores early positive data for new JAK drug
biopharma dive
Jun 8, 26
Incyte CEO sees $2B Vega deal aiding a post-Jakafi future
endpoints
Jun 8, 26
Incyte to buy blood disorder drug in possibly $2B deal
biopharma dive
May 10, 26
Five Under 5: Top Oncology Videos for the Week of 5/3
onclive
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
